Skip to content
  • Home
  • Contact Us
  • About Us
  • Sitemap
  • Home
  • Contact Us
  • About Us
  • Sitemap
  • General
  • Business
  • Education
  • Government
  • Medical
  • Entertainment
  • Sports
  • French
  • Press Releases
    • PR-French
  • General
  • Business
  • Education
  • Government
  • Medical
  • Entertainment
  • Sports
  • French
  • Press Releases
    • PR-French
Search
Category: Press Releases

Un rapport de recherche publié par Bitget souligne que le volume des transactions de l’écosystème TON a augmenté de 1 800 % en moins de six mois

September 20, 2024

VICTORIA, Seychelles, 20 sept. 2024 (GLOBE NEWSWIRE) — Bitget, principale bourse de crypto-monnaie et société Web3, a publié un rapport détaillé qui décrit l’état actuel et

Read More

Un rapport de recherche publié par Bitget souligne que le volume des transactions de l’écosystème TON a augmenté de 1 800 % en moins de six mois

September 20, 2024

VICTORIA, Seychelles, 20 sept. 2024 (GLOBE NEWSWIRE) — Bitget, principale bourse de crypto-monnaie et société Web3, a publié un rapport détaillé qui décrit l’état actuel et

Read More

Un rapport de recherche publié par Bitget souligne que le volume des transactions de l’écosystème TON a augmenté de 1 800 % en moins de six mois

September 20, 2024

VICTORIA, Seychelles, 20 sept. 2024 (GLOBE NEWSWIRE) — Bitget, principale bourse de crypto-monnaie et société Web3, a publié un rapport détaillé qui décrit l’état actuel et

Read More

Zenas BioPharma Announces Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares in Initial Public Offering

September 20, 2024

WALTHAM, Mass., Sept. 19, 2024 (GLOBE NEWSWIRE) — Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical company committed to being a leader in

Read More

Zenas BioPharma Announces Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares in Initial Public Offering

September 20, 2024

WALTHAM, Mass., Sept. 19, 2024 (GLOBE NEWSWIRE) — Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical company committed to being a leader in

Read More

Zenas BioPharma Announces Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares in Initial Public Offering

September 20, 2024

WALTHAM, Mass., Sept. 19, 2024 (GLOBE NEWSWIRE) — Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical company committed to being a leader in

Read More
Page1 … Page414 Page415 Page416 Page417 Page418 … Page450
RECENT POSTS

Ebola Outbreak in Eastern DR Congo Claims Over 300 Children; New Vaccine Trials Recommended

August 7, 2026

DR Congo Ebola Outbreak Surpasses 4,000 Cases Amidst Expanding Health Response

August 7, 2026

Ebola Cases Surpass 4,000 in Democratic Republic of Congo

August 7, 2026

Antwerp Confronts Colonial Past with Monument to Human Zoo Victims

August 7, 2026

Ebola Death Toll Tops 1,800 in DRC

August 7, 2026

DRCs Largest Ebola Outbreak on Record: Active Conflict and Armed Groups Hamper the Response

August 7, 2026

Nigeria Slashes Malaria Burden To 15 Pct Over 15 Years

August 6, 2026

At Least 308 Kidnapped Victims Rescued In Nigerian Military Operation

August 6, 2026
Copyright © 2026 Le Congo Tribune. All Rights Reserved.